feed,title,long_url,short_url
Benzinga,40 Stocks Moving In Wednesday's Mid-Day Session,https://benzinga.com/news/21/06/21393215/40-stocks-moving-in-wednesdays-mid-day-session,https://j.mp/3icpIkw
Benzinga,Almost Half of Crohn's Disease Patients Achieved Endoscopic Response After One Year of Maintenance Treatment with AbbVie's Risankizumab,https://benzinga.com/general/biotech/21/06/21390222/almost-half-of-crohns-disease-patients-achieved-endoscopic-response-after-one-year-of-maintenance,https://j.mp/3ceSvkR
